Letter: rising incidence and poor survival in patients with nonviral <scp>HCC</scp>—better <scp>HCC</scp> surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed
Richie Manikat(Stanford University), Mindie H. Nguyen(Stanford Medicine)
Cited by 1
Related Papers
Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
|JAMA Network Open|2020|62
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Nonalcoholic fatty liver disease and non-liver comorbidities
|Clinical and Molecular Hepatology|2023|37
The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
|Journal of Pediatric Gastroenterology and Nutrition|2024|25